Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

102.48 -0.96 (-0.93%)
Streaming Delayed Price Updated: 2:09 PM EDT, Apr 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Moderna Inc

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
99 100 Next >
Don’t Let the Q3 Earnings Miss Keep You From These 3 Stocks!
Few S&P 500 companies didn’t meet or exceed Q3 2023 earnings estimates. Here are three earnings miss investment opportunities. 
Via InvestorPlace
Topics Earnings Stocks
Exposures Financial US Equities
Big Players' Recent Trades in MRNA Options
Via Benzinga
Peering Into Moderna's Recent Short Interest
Via Benzinga
3 Cathie Wood Bargain Buys That Should Be on Your List Too
Wood just picked up shares of these companies recently. 
Via The Motley Fool
Where Will Novavax Be in 3 Years?
Novavax shares have plunged from early pandemic highs. 
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
2 Top Biotech Stocks to Buy Right Now
Don't give up on these stocks too fast. 
Via The Motley Fool
Moderna Unusual Options Activity For November 08
Via Benzinga
Why Moderna Stock Plummeted by Almost 7% Today
Many investors felt queasy after reviewing the company's latest earnings report. 
Via The Motley Fool
Why Moderna Stock Was Cratering This Week
Perhaps the COVID-19 vaccine developer's best days are in the past. 
Via The Motley Fool
Exposures COVID-19
Moderna's Stock Just Tumbled 12%. Here's Why It's Still a Buy.
It's gearing up for its next growth spurt. 
Via The Motley Fool
6 Nasdaq 100 Stocks Down 40% or More that Will Soar As Much 367%
Wall Street is forever optimistic about the future for stocks and pegs these seven Nasdaq 100 stocks as ready for supersonic growth 
Via InvestorPlace
High Risk Alert: 7 Vulnerable Stocks to Dump Now
The economy is showing weakness. These seven stocks at risk could be at the center of the coming bust. 
Via InvestorPlace
Topics Economy
Exposures Economy
BioNTech Shifted Its Focus To Innovative Oncology And Mainz Biomed Announced A Showcasing Of Its Revolutionary Colorectal Cancer Detection Test
On November 6th, BioNTech SE (NASADQ: SE) who partnered with Pfizer Inc (NYSE: PFE) in the making of a blockbuster COVID-19 vaccine, posted a surprise earnings with its latest quarterly report. 
Via Benzinga
Exposures COVID-19
Is It Time to Buy the S&P 500's 4 Worst-Performing Stocks This Year?
Should you buy the dip on these S&P 500 stocks? 
Via The Motley Fool
Topics Stocks
Exposures US Equities
Cathie Wood Just Bought This Struggling Stock After Its Billion-Dollar Quarterly Loss. Should You?
This particular stock has dropped more than 50% this year. 
Via The Motley Fool
Like Moderna, BioNTech Cuts Annual Sales Forecast By 20% As Pandemic Fades
BioNTech SE (NASDAQ: BNTX) has reported Q3 revenues of €895.3 million ($974.49 million), sharply down from €3.461 billion a year ago. 
Via Benzinga
Down 84% From Its Peak. Is It Finally Time to Buy Moderna?
The vaccine developer's huge profits have turned into heavy losses. 
Via The Motley Fool
Moderna May Be Facing Its Toughest Moment Ever. Time to Sell?
Moderna still has big ambitions -- beyond the coronavirus vaccine -- that could pay off in a few years. 
Via The Motley Fool
Exposures COVID-19
These Analysts Cut Their Forecasts On Moderna After Q3 Results
Moderna Inc (NASDAQ: MRNA) posted a loss for the third quarter on Thursday. 
Via Benzinga
Cyberark Software To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Friday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
Cathie Wood's Ark Invest Goes Shopping For Moderna Stock — Sells DraftKings Shares Amid Quarterly Rise In Revenue, EPS Beat
Via Benzinga
Earnings Recap: Shell, Palantir, Starbucks, Shopify Rise; Moderna Falls
Shares of Shell, Palantir, Starbucks, and Shopify all rose higher on Thursday following better-than-expected earnings reports. 
Via Talk Markets
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Moderna (MRNA) Q3 2023 Earnings Call Transcript
MRNA earnings call for the period ending September 30, 2023. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Moderna Struggles With Weaker COVID-19 Vaccine Demand, Expects To Return To Growth In 2025, Stock Plunges
Moderna Inc (NASDAQ: MRNA) shares are trading lower after the company reported a deeper Q3 loss of $(9.53), down from EPS income of $2.53. 
Via Benzinga
Exposures COVID-19
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
US Stocks On Track For Solid Start Amid Lingering Fed Optimism: Traders Eye Earnings From Market Bellwether Apple
After the Federal Reserve‘s decision, the stock market rally is poised to gain momentum on Thursday, with stock futures indicating an uptick. 
Via Benzinga
Topics Economy
Exposures Interest Rates
Moderna Beats Sales Forecasts, But Light Guidance Could Rattle Shares
The company issued below-consensus sales views for 2023 and 2024. 
Via Investor's Business Daily
Healthcare Playbook: Hardly Defensive With A Covid Hangover In Biotech
Market Bubbles may take a long time to clear and we created a big one in July 2021 dealing with the COVID pandemic. 
Via Talk Markets
Exposures COVID-19
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.